PTGS2 and cancer: Expression of cyclooxygenase-2 (COX-2) and prostaglandin E2 (PGE2) have been found increased in a variety of malignant tumours, including neuroblastoma [4,5] and pharmacological inhibition of COX-2 has been shown to attenuate cell cycle progression in malignant cells [6–9].